TY - GEN T1 - Cost consequence analysis of using the Elecsys Anti-Müllerian Hormone Plus immunoassay as part of polycystic ovary syndrome assessment in the United Kingdom PY - 2024/11/18 AU - Mawson R ED - Y2 - 2024/12/21 ER -